Effects Of Magnesium And Vitamin B6 On The Severity Of Premenstrual Syndrome Symptoms
Notes for this study:
||Premenstrual diary. Mean + SD change. Placebo: 0.000 (20.41) Magnesium: -12.14 (26.14)
|Number of Subjects
In a randomized, double-blind, placebo-controlled trial, 126 women with premenstrual syndrome were allocated to take 250 mg of magnesium from magnesium oxide, vitamin B6, or placebo daily for 4 months.
At the end of the 4 months, there was a reduction in mean symptoms in all groups but were reduced somewhat more in the magnesium and vitamin B6 groups, which was statistically significant compared with the placebo group. This was derived from cravings, depression, water retention, anxiety, and somatic changes on the Abraham's classification.